Completed
An Open Label Study of ANX005 in Participants With, or at Risk for, Manifest Huntington's Disease
NCT04514367
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Annexon Investigational Site 02 Birmingham, Alabama, United States
- Annexon Investigational Site 03 Englewood, Colorado, United States
- Annexon Investigational Site 04 Washington D.C., District of Columbia, United States
- Annexon Investigational Site 07 Durham, North Carolina, United States